Strauer B E
Department of Medicine, University of Düsseldorf, West Germany.
Am J Med. 1988 Mar 11;84(3A):45-54. doi: 10.1016/0002-9343(88)90204-5.
Myocardial hypertrophy may influence coronary hemodynamics variably. Therefore, coronary sinus blood flow (gas chromatic argon technique) was determined in patients with left ventricular hypertrophy, with or without dilatation, associated with entirely normal coronary arteriographic results: 12 patients with hypertrophic obstructive cardiomyopathy (left ventricular mass-to-volume ratio, 3.66 +/- 0.52 g/ml), 22 patients with hypertensive heart disease due to essential hypertension (left ventricular mass-to-volume ratio, 2.12 +/- 0.26 g/ml), 18 patients with hypertensive dilatation (left ventricular mass-to-volume ratio, 1.6 +/- 0.48 g/ml), six patients with aortic stenosis (left ventricular mass-to-volume ratio, 1.99 +/- 0.41 g/ml), 12 patients with aortic incompetence, and 20 patients with normal heart function. Coronary sinus blood flow was determined as a control value and as the value following intravenous injection of dipyridamole (0.5 mg/kg of body weight). Coronary reserve was calculated as the ratio of coronary resistance before and after dipyridamole. Normal coronary reserve averaged 4.89 +/- 0.11. Similar values, despite marked left ventricular hypertrophy, were present for both hypertrophic obstructive cardiomyopathy (4.4 +/- 0.19) and aortic stenosis (4.66 +/- 0.12), whereas coronary reserve was considerably reduced in the concentrically hypertrophied hypertensive hearts (3.22 +/- 0.19) (p less than 0.001). Moderate decrease in coronary reserve was found in aortic incompetence and in dilated essential hypertension. These results indicate that patients with nonhypertensive hypertrophy, despite left ventricular mass augmentation, may have normal coronary reserve, whereas at a comparable degree of left ventricular hypertrophy, patients with hypertensive hypertrophy have a specific reduction in coronary reserve. Independent from vascular effects, ventricular dilatation may result in deterioration of coronary reserve because of an abnormal component of coronary vascular resistance. These results were also verified in experimental hypertension. Moreover, prevention and/or regression of the impaired coronary circulation in experimental hypertensive heart disease, most probably due to the reduction of smooth muscle layers of the media of coronary resistance vessels, could be achieved by long-term vasodilator therapy.
心肌肥厚可能对冠状动脉血流动力学产生不同影响。因此,我们采用气相色谱氩气技术测定了左心室肥厚患者(无论有无扩张)的冠状窦血流量,这些患者的冠状动脉造影结果完全正常:12例肥厚性梗阻性心肌病患者(左心室质量与容积比为3.66±0.52 g/ml)、22例原发性高血压所致高血压性心脏病患者(左心室质量与容积比为2.12±0.26 g/ml)、18例高血压性扩张患者(左心室质量与容积比为1.6±0.48 g/ml)、6例主动脉瓣狭窄患者(左心室质量与容积比为1.99±0.41 g/ml)、12例主动脉瓣关闭不全患者以及20例心功能正常的患者。测定了冠状窦血流量的对照值以及静脉注射双嘧达莫(0.5 mg/kg体重)后的数值。冠状动脉储备通过双嘧达莫注射前后冠状动脉阻力的比值计算得出。正常冠状动脉储备平均为4.89±0.11。肥厚性梗阻性心肌病(4.4±0.19)和主动脉瓣狭窄(4.66±0.12)患者尽管存在明显的左心室肥厚,但冠状动脉储备值相似,而向心性肥厚的高血压性心脏患者的冠状动脉储备则显著降低(3.22±0.19)(p<0.001)。在主动脉瓣关闭不全和扩张型原发性高血压患者中发现冠状动脉储备有中度降低。这些结果表明,非高血压性肥厚患者尽管左心室质量增加,但冠状动脉储备可能正常,而在左心室肥厚程度相当的情况下,高血压性肥厚患者的冠状动脉储备会有特异性降低。独立于血管效应之外,心室扩张可能由于冠状动脉血管阻力的异常成分而导致冠状动脉储备恶化。这些结果在实验性高血压中也得到了验证。此外,通过长期血管扩张剂治疗,有可能预防和/或逆转实验性高血压性心脏病中受损的冠状动脉循环,这很可能是由于冠状动脉阻力血管中膜平滑肌层的减少所致。